NCT05910450 - A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss | Biotech Hunter

Enrollment

726

Participants

Timeline

Start Date

June 21, 2023

Primary Completion Date

October 31, 2024

Study Completion Date

April 30, 2025

Conditions

Alopecia, Androgenetic

Interventions

DRUG

Clascoterone 5% solution

Topical application of 1.5 ml of clascoterone solution 5%, twice a day, to balding areas of the scalp (vertex and temples)

DRUG

Vehicle solution

Topical application of 1.5 ml of vehicle, twice a day, to balding areas of the scalp (vertex and temples)

Trial Locations (24)

6000

RECRUITING

LTD Health, Batumi

10022

RECRUITING

Diane S. Berson MD, PLLC, New York

11790

RECRUITING

Derm Research Center of New York, Inc., Stony Brook

28277

RECRUITING

On Site Clinical Solutions, Charlotte

32224

RECRUITING

Mayo Clinic, Department of Dermatology, Jacksonville

33125

NOT_YET_RECRUITING

University of Miami, Miami

48202

RECRUITING

Henry Ford Health, Detroit

55455

RECRUITING

University of Minnesota, Minneapolis

70115

RECRUITING

DelRicht Research, New Orleans

70809

RECRUITING

DelRicht Research, Baton Rouge

72116

RECRUITING

The Petrus Center for Aesthetic Surgery and Hair Transplantation, North Little Rock

75034

RECRUITING

DelRicht Research, Frisco

78213

RECRUITING

Progressive Clinical Research, San Antonio

78759

RECRUITING

DermResearch, Austin

89148

RECRUITING

JDR Dermatology Research, Las Vegas

92123

RECRUITING

Therapeutics Clinical Research, San Diego

08009

RECRUITING

Hassman Research Institute, Berlin

0114

RECRUITING

JSC Curatio, Tbilisi

0159

RECRUITING

Kanveni National Center of Dermatology and Venerology, Tbilisi

RECRUITING

Tbilisi Cancer Center, Tbilisi

0160

RECRUITING

Aversi Clinic, Tbilisi

RECRUITING

Medi Club, Tbilisi

0179

RECRUITING

David Abuladze Georgian-Italian Clinic, Tbilisi

0186

RECRUITING

"LTD Medinvestment", Tbilisi